Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
7,711
archived clinical trials in
Depression

Effectiveness of Cognitive Processing Therapy in Pregnant Women With a History of Pregnancy Loss/Complication
Effectiveness of Cognitive Processing Therapy in Reducing Post-traumatic Symptoms and Enhancing Birth Outcomes in Pregnant Women With a Previous Pregnancy Loss or Complication
Status: Archived
Penn Center for Women's Behavioral Wellness, University of Pennsylvania
mi
from
Philadelphia, PA
Effectiveness of Cognitive Processing Therapy in Pregnant Women With a History of Pregnancy Loss/Complication
Effectiveness of Cognitive Processing Therapy in Reducing Post-traumatic Symptoms and Enhancing Birth Outcomes in Pregnant Women With a Previous Pregnancy Loss or Complication
Status: Archived
Updated: 1/1/1970
Penn Center for Women's Behavioral Wellness, University of Pennsylvania
mi
from
Philadelphia, PA
Effectiveness of Cognitive Processing Therapy in Pregnant Women With a History of Pregnancy Loss/Complication
Effectiveness of Cognitive Processing Therapy in Reducing Post-traumatic Symptoms and Enhancing Birth Outcomes in Pregnant Women With a Previous Pregnancy Loss or Complication
Status: Archived
University of Pennsylvania, Pennsylvania Hospital Department of Neurology , 330 South 9Th Street
mi
from
Philadelphia, PA
Effectiveness of Cognitive Processing Therapy in Pregnant Women With a History of Pregnancy Loss/Complication
Effectiveness of Cognitive Processing Therapy in Reducing Post-traumatic Symptoms and Enhancing Birth Outcomes in Pregnant Women With a Previous Pregnancy Loss or Complication
Status: Archived
Updated: 1/1/1970
University of Pennsylvania, Pennsylvania Hospital Department of Neurology , 330 South 9Th Street
mi
from
Philadelphia, PA
Effectiveness of Cognitive Processing Therapy in Pregnant Women With a History of Pregnancy Loss/Complication
Effectiveness of Cognitive Processing Therapy in Reducing Post-traumatic Symptoms and Enhancing Birth Outcomes in Pregnant Women With a Previous Pregnancy Loss or Complication
Status: Archived
Penn OB/GYN Associates
mi
from
Philadelphia, PA
Effectiveness of Cognitive Processing Therapy in Pregnant Women With a History of Pregnancy Loss/Complication
Effectiveness of Cognitive Processing Therapy in Reducing Post-traumatic Symptoms and Enhancing Birth Outcomes in Pregnant Women With a Previous Pregnancy Loss or Complication
Status: Archived
Updated: 1/1/1970
Penn OB/GYN Associates
mi
from
Philadelphia, PA
Safety and Efficacy of RX-10100 to Treat Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 2 Study of RX-10100 in Subjects With Major Depressive Disorder.
Status: Archived
Rexahn Investigative Site
mi
from
Cerritos, CA
Safety and Efficacy of RX-10100 to Treat Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 2 Study of RX-10100 in Subjects With Major Depressive Disorder.
Status: Archived
Updated: 1/1/1970
Rexahn Investigative Site
mi
from
Cerritos, CA
Safety and Efficacy of RX-10100 to Treat Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 2 Study of RX-10100 in Subjects With Major Depressive Disorder.
Status: Archived
Rexahn Investigative Site
mi
from
Denver, CO
Safety and Efficacy of RX-10100 to Treat Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 2 Study of RX-10100 in Subjects With Major Depressive Disorder.
Status: Archived
Updated: 1/1/1970
Rexahn Investigative Site
mi
from
Denver, CO
Safety and Efficacy of RX-10100 to Treat Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 2 Study of RX-10100 in Subjects With Major Depressive Disorder.
Status: Archived
Rexahn Investigative Site
mi
from
Brooksville, FL
Safety and Efficacy of RX-10100 to Treat Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 2 Study of RX-10100 in Subjects With Major Depressive Disorder.
Status: Archived
Updated: 1/1/1970
Rexahn Investigative Site
mi
from
Brooksville, FL
Safety and Efficacy of RX-10100 to Treat Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 2 Study of RX-10100 in Subjects With Major Depressive Disorder.
Status: Archived
Rexahn Investigative Site
mi
from
Owensboro, KY
Safety and Efficacy of RX-10100 to Treat Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 2 Study of RX-10100 in Subjects With Major Depressive Disorder.
Status: Archived
Updated: 1/1/1970
Rexahn Investigative Site
mi
from
Owensboro, KY
Safety and Efficacy of RX-10100 to Treat Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 2 Study of RX-10100 in Subjects With Major Depressive Disorder.
Status: Archived
Rexahn Investigative Site
mi
from
Atlanta, GA
Safety and Efficacy of RX-10100 to Treat Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 2 Study of RX-10100 in Subjects With Major Depressive Disorder.
Status: Archived
Updated: 1/1/1970
Rexahn Investigative Site
mi
from
Atlanta, GA
Safety and Efficacy of RX-10100 to Treat Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 2 Study of RX-10100 in Subjects With Major Depressive Disorder.
Status: Archived
Rexahn Investigative Site
mi
from
Oak Brook, IL
Safety and Efficacy of RX-10100 to Treat Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 2 Study of RX-10100 in Subjects With Major Depressive Disorder.
Status: Archived
Updated: 1/1/1970
Rexahn Investigative Site
mi
from
Oak Brook, IL
Safety and Efficacy of RX-10100 to Treat Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 2 Study of RX-10100 in Subjects With Major Depressive Disorder.
Status: Archived
Rexahn Investigative Site
mi
from
Las Vegas, NV
Safety and Efficacy of RX-10100 to Treat Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 2 Study of RX-10100 in Subjects With Major Depressive Disorder.
Status: Archived
Updated: 1/1/1970
Rexahn Investigative Site
mi
from
Las Vegas, NV
Safety and Efficacy of RX-10100 to Treat Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 2 Study of RX-10100 in Subjects With Major Depressive Disorder.
Status: Archived
Rexahn Investigative site
mi
from
Cherry Hill, NJ
Safety and Efficacy of RX-10100 to Treat Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 2 Study of RX-10100 in Subjects With Major Depressive Disorder.
Status: Archived
Updated: 1/1/1970
Rexahn Investigative site
mi
from
Cherry Hill, NJ
Safety and Efficacy of RX-10100 to Treat Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 2 Study of RX-10100 in Subjects With Major Depressive Disorder.
Status: Archived
Rexahn Investigative Site
mi
from
Albuquerque, NM
Safety and Efficacy of RX-10100 to Treat Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 2 Study of RX-10100 in Subjects With Major Depressive Disorder.
Status: Archived
Updated: 1/1/1970
Rexahn Investigative Site
mi
from
Albuquerque, NM
Safety and Efficacy of RX-10100 to Treat Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 2 Study of RX-10100 in Subjects With Major Depressive Disorder.
Status: Archived
Rexahn Investigative Site
mi
from
Fresh Meadows, NY
Safety and Efficacy of RX-10100 to Treat Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 2 Study of RX-10100 in Subjects With Major Depressive Disorder.
Status: Archived
Updated: 1/1/1970
Rexahn Investigative Site
mi
from
Fresh Meadows, NY
Safety and Efficacy of RX-10100 to Treat Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 2 Study of RX-10100 in Subjects With Major Depressive Disorder.
Status: Archived
Rexahn Investigative Site
mi
from
Cincinnati, OH
Safety and Efficacy of RX-10100 to Treat Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 2 Study of RX-10100 in Subjects With Major Depressive Disorder.
Status: Archived
Updated: 1/1/1970
Rexahn Investigative Site
mi
from
Cincinnati, OH
Safety and Efficacy of RX-10100 to Treat Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 2 Study of RX-10100 in Subjects With Major Depressive Disorder.
Status: Archived
Rexahn Investigative Site
mi
from
Oklahoma City, OK
Safety and Efficacy of RX-10100 to Treat Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 2 Study of RX-10100 in Subjects With Major Depressive Disorder.
Status: Archived
Updated: 1/1/1970
Rexahn Investigative Site
mi
from
Oklahoma City, OK
Safety and Efficacy of RX-10100 to Treat Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 2 Study of RX-10100 in Subjects With Major Depressive Disorder.
Status: Archived
Rexahn Investigative site
mi
from
Allentown, PA
Safety and Efficacy of RX-10100 to Treat Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 2 Study of RX-10100 in Subjects With Major Depressive Disorder.
Status: Archived
Updated: 1/1/1970
Rexahn Investigative site
mi
from
Allentown, PA
Safety and Efficacy of RX-10100 to Treat Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 2 Study of RX-10100 in Subjects With Major Depressive Disorder.
Status: Archived
Rexahn Investigative Site
mi
from
Anderson, SC
Safety and Efficacy of RX-10100 to Treat Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 2 Study of RX-10100 in Subjects With Major Depressive Disorder.
Status: Archived
Updated: 1/1/1970
Rexahn Investigative Site
mi
from
Anderson, SC
Safety and Efficacy of RX-10100 to Treat Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 2 Study of RX-10100 in Subjects With Major Depressive Disorder.
Status: Archived
Rexahn Investigative Site
mi
from
Memphis, TN
Safety and Efficacy of RX-10100 to Treat Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 2 Study of RX-10100 in Subjects With Major Depressive Disorder.
Status: Archived
Updated: 1/1/1970
Rexahn Investigative Site
mi
from
Memphis, TN
Safety and Efficacy of RX-10100 to Treat Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 2 Study of RX-10100 in Subjects With Major Depressive Disorder.
Status: Archived
Rexahn Investigative Site
mi
from
Austin, TX
Safety and Efficacy of RX-10100 to Treat Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 2 Study of RX-10100 in Subjects With Major Depressive Disorder.
Status: Archived
Updated: 1/1/1970
Rexahn Investigative Site
mi
from
Austin, TX
Safety and Efficacy of RX-10100 to Treat Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 2 Study of RX-10100 in Subjects With Major Depressive Disorder.
Status: Archived
Rexahn Investigative Sites
mi
from
Lake Jackson, TX
Safety and Efficacy of RX-10100 to Treat Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 2 Study of RX-10100 in Subjects With Major Depressive Disorder.
Status: Archived
Updated: 1/1/1970
Rexahn Investigative Sites
mi
from
Lake Jackson, TX
Safety and Efficacy of RX-10100 to Treat Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 2 Study of RX-10100 in Subjects With Major Depressive Disorder.
Status: Archived
Rexahn Investigative Site
mi
from
Orem, UT
Safety and Efficacy of RX-10100 to Treat Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 2 Study of RX-10100 in Subjects With Major Depressive Disorder.
Status: Archived
Updated: 1/1/1970
Rexahn Investigative Site
mi
from
Orem, UT
Safety and Efficacy of RX-10100 to Treat Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 2 Study of RX-10100 in Subjects With Major Depressive Disorder.
Status: Archived
Rexahn Investigative Site
mi
from
Richmond, VA
Safety and Efficacy of RX-10100 to Treat Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 2 Study of RX-10100 in Subjects With Major Depressive Disorder.
Status: Archived
Updated: 1/1/1970
Rexahn Investigative Site
mi
from
Richmond, VA
Safety and Efficacy of RX-10100 to Treat Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 2 Study of RX-10100 in Subjects With Major Depressive Disorder.
Status: Archived
Rexahn Investigative Site
mi
from
Bellevue, WA
Safety and Efficacy of RX-10100 to Treat Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 2 Study of RX-10100 in Subjects With Major Depressive Disorder.
Status: Archived
Updated: 1/1/1970
Rexahn Investigative Site
mi
from
Bellevue, WA
Second-Generation Antipsychotic Treatment Indication Effectiveness And Tolerability In Youth (Satiety) Study
Second-Generation Antipsychotic Treatment Indication Effectiveness And Tolerability In Youth (Satiety) Study
Status: Archived
University of North Carolina Hospital at Chapel Hill
mi
from
Chapel Hill, NC
Second-Generation Antipsychotic Treatment Indication Effectiveness And Tolerability In Youth (Satiety) Study
Second-Generation Antipsychotic Treatment Indication Effectiveness And Tolerability In Youth (Satiety) Study
Status: Archived
Updated: 1/1/1970
University of North Carolina Hospital at Chapel Hill
mi
from
Chapel Hill, NC
Psychosocial Treatment for Women With Depression and Pain
Psychosocial Treatment for Gynecology Patients With Comorbid Depression and Pain
Status: Archived
Strong Memorial Hospital (University of Rochester School of Medicine)
mi
from
Rochester, NY
Psychosocial Treatment for Women With Depression and Pain
Psychosocial Treatment for Gynecology Patients With Comorbid Depression and Pain
Status: Archived
Updated: 1/1/1970
Strong Memorial Hospital (University of Rochester School of Medicine)
mi
from
Rochester, NY
Feasibility of Telehealth Problem-Solving Therapy for Depressed Homebound Older Adults
Telehealth Problem-Solving Therapy for Depressed Homebound Older Adults
Status: Archived
University of Texas at Austin
mi
from
Austin, TX
Feasibility of Telehealth Problem-Solving Therapy for Depressed Homebound Older Adults
Telehealth Problem-Solving Therapy for Depressed Homebound Older Adults
Status: Archived
Updated: 1/1/1970
University of Texas at Austin
mi
from
Austin, TX
Evaluation of the Brainsway Deep Transcranial Magnetic Stimulation (TMS) H-Coil in the Treatment of Major Depression Disorder
A Prospective Multicenter Double Blind Randomized Controlled Trial to Explore the Tolerability, Safety and Efficacy of the H-Coil Deep Transcranial Magnetic Stimulation (TMS) in Subjects With Major Depression Disorder (MDD)
Status: Archived
David Geffen School of Medicine, UCLA
mi
from
Los Angeles, CA
Evaluation of the Brainsway Deep Transcranial Magnetic Stimulation (TMS) H-Coil in the Treatment of Major Depression Disorder
A Prospective Multicenter Double Blind Randomized Controlled Trial to Explore the Tolerability, Safety and Efficacy of the H-Coil Deep Transcranial Magnetic Stimulation (TMS) in Subjects With Major Depression Disorder (MDD)
Status: Archived
Updated: 1/1/1970
David Geffen School of Medicine, UCLA
mi
from
Los Angeles, CA
Evaluation of the Brainsway Deep Transcranial Magnetic Stimulation (TMS) H-Coil in the Treatment of Major Depression Disorder
A Prospective Multicenter Double Blind Randomized Controlled Trial to Explore the Tolerability, Safety and Efficacy of the H-Coil Deep Transcranial Magnetic Stimulation (TMS) in Subjects With Major Depression Disorder (MDD)
Status: Archived
University of California, San Francisco, Fresno, School of Medicine
mi
from
Fresno, CA
Evaluation of the Brainsway Deep Transcranial Magnetic Stimulation (TMS) H-Coil in the Treatment of Major Depression Disorder
A Prospective Multicenter Double Blind Randomized Controlled Trial to Explore the Tolerability, Safety and Efficacy of the H-Coil Deep Transcranial Magnetic Stimulation (TMS) in Subjects With Major Depression Disorder (MDD)
Status: Archived
Updated: 1/1/1970
University of California, San Francisco, Fresno, School of Medicine
mi
from
Fresno, CA
Evaluation of the Brainsway Deep Transcranial Magnetic Stimulation (TMS) H-Coil in the Treatment of Major Depression Disorder
A Prospective Multicenter Double Blind Randomized Controlled Trial to Explore the Tolerability, Safety and Efficacy of the H-Coil Deep Transcranial Magnetic Stimulation (TMS) in Subjects With Major Depression Disorder (MDD)
Status: Archived
Advanced Mental Health Care Inc. - Juno Beach
mi
from
Juno Beach, FL
Evaluation of the Brainsway Deep Transcranial Magnetic Stimulation (TMS) H-Coil in the Treatment of Major Depression Disorder
A Prospective Multicenter Double Blind Randomized Controlled Trial to Explore the Tolerability, Safety and Efficacy of the H-Coil Deep Transcranial Magnetic Stimulation (TMS) in Subjects With Major Depression Disorder (MDD)
Status: Archived
Updated: 1/1/1970
Advanced Mental Health Care Inc. - Juno Beach
mi
from
Juno Beach, FL
Evaluation of the Brainsway Deep Transcranial Magnetic Stimulation (TMS) H-Coil in the Treatment of Major Depression Disorder
A Prospective Multicenter Double Blind Randomized Controlled Trial to Explore the Tolerability, Safety and Efficacy of the H-Coil Deep Transcranial Magnetic Stimulation (TMS) in Subjects With Major Depression Disorder (MDD)
Status: Archived
Advanced Mental Health Care Inc. - Royal Palm Beach
mi
from
Royal Palm Beach, FL
Evaluation of the Brainsway Deep Transcranial Magnetic Stimulation (TMS) H-Coil in the Treatment of Major Depression Disorder
A Prospective Multicenter Double Blind Randomized Controlled Trial to Explore the Tolerability, Safety and Efficacy of the H-Coil Deep Transcranial Magnetic Stimulation (TMS) in Subjects With Major Depression Disorder (MDD)
Status: Archived
Updated: 1/1/1970
Advanced Mental Health Care Inc. - Royal Palm Beach
mi
from
Royal Palm Beach, FL
Evaluation of the Brainsway Deep Transcranial Magnetic Stimulation (TMS) H-Coil in the Treatment of Major Depression Disorder
A Prospective Multicenter Double Blind Randomized Controlled Trial to Explore the Tolerability, Safety and Efficacy of the H-Coil Deep Transcranial Magnetic Stimulation (TMS) in Subjects With Major Depression Disorder (MDD)
Status: Archived
Johns Hopkins University
mi
from
Baltimore, MD
Evaluation of the Brainsway Deep Transcranial Magnetic Stimulation (TMS) H-Coil in the Treatment of Major Depression Disorder
A Prospective Multicenter Double Blind Randomized Controlled Trial to Explore the Tolerability, Safety and Efficacy of the H-Coil Deep Transcranial Magnetic Stimulation (TMS) in Subjects With Major Depression Disorder (MDD)
Status: Archived
Updated: 1/1/1970
Johns Hopkins University
mi
from
Baltimore, MD
Evaluation of the Brainsway Deep Transcranial Magnetic Stimulation (TMS) H-Coil in the Treatment of Major Depression Disorder
A Prospective Multicenter Double Blind Randomized Controlled Trial to Explore the Tolerability, Safety and Efficacy of the H-Coil Deep Transcranial Magnetic Stimulation (TMS) in Subjects With Major Depression Disorder (MDD)
Status: Archived
McLean Hospital
mi
from
Belmont, MA
Evaluation of the Brainsway Deep Transcranial Magnetic Stimulation (TMS) H-Coil in the Treatment of Major Depression Disorder
A Prospective Multicenter Double Blind Randomized Controlled Trial to Explore the Tolerability, Safety and Efficacy of the H-Coil Deep Transcranial Magnetic Stimulation (TMS) in Subjects With Major Depression Disorder (MDD)
Status: Archived
Updated: 1/1/1970
McLean Hospital
mi
from
Belmont, MA
Evaluation of the Brainsway Deep Transcranial Magnetic Stimulation (TMS) H-Coil in the Treatment of Major Depression Disorder
A Prospective Multicenter Double Blind Randomized Controlled Trial to Explore the Tolerability, Safety and Efficacy of the H-Coil Deep Transcranial Magnetic Stimulation (TMS) in Subjects With Major Depression Disorder (MDD)
Status: Archived
Columbia Presbyterian Med Ctr
mi
from
New York, NY
Evaluation of the Brainsway Deep Transcranial Magnetic Stimulation (TMS) H-Coil in the Treatment of Major Depression Disorder
A Prospective Multicenter Double Blind Randomized Controlled Trial to Explore the Tolerability, Safety and Efficacy of the H-Coil Deep Transcranial Magnetic Stimulation (TMS) in Subjects With Major Depression Disorder (MDD)
Status: Archived
Updated: 1/1/1970
Columbia Presbyterian Med Ctr
mi
from
New York, NY
Evaluation of the Brainsway Deep Transcranial Magnetic Stimulation (TMS) H-Coil in the Treatment of Major Depression Disorder
A Prospective Multicenter Double Blind Randomized Controlled Trial to Explore the Tolerability, Safety and Efficacy of the H-Coil Deep Transcranial Magnetic Stimulation (TMS) in Subjects With Major Depression Disorder (MDD)
Status: Archived
Medical University of South Carolina
mi
from
Charleston, SC
Evaluation of the Brainsway Deep Transcranial Magnetic Stimulation (TMS) H-Coil in the Treatment of Major Depression Disorder
A Prospective Multicenter Double Blind Randomized Controlled Trial to Explore the Tolerability, Safety and Efficacy of the H-Coil Deep Transcranial Magnetic Stimulation (TMS) in Subjects With Major Depression Disorder (MDD)
Status: Archived
Updated: 1/1/1970
Medical University of South Carolina
mi
from
Charleston, SC
Evaluation of the Brainsway Deep Transcranial Magnetic Stimulation (TMS) H-Coil in the Treatment of Major Depression Disorder
A Prospective Multicenter Double Blind Randomized Controlled Trial to Explore the Tolerability, Safety and Efficacy of the H-Coil Deep Transcranial Magnetic Stimulation (TMS) in Subjects With Major Depression Disorder (MDD)
Status: Archived
UT Soutwestern Medical Center at Dallas
mi
from
Dallas, TX
Evaluation of the Brainsway Deep Transcranial Magnetic Stimulation (TMS) H-Coil in the Treatment of Major Depression Disorder
A Prospective Multicenter Double Blind Randomized Controlled Trial to Explore the Tolerability, Safety and Efficacy of the H-Coil Deep Transcranial Magnetic Stimulation (TMS) in Subjects With Major Depression Disorder (MDD)
Status: Archived
Updated: 1/1/1970
UT Soutwestern Medical Center at Dallas
mi
from
Dallas, TX
Therapy Targeting Depression and HIV Treatment Adherence (The TRIAD Study)
Efficacy of CBT for Adherence and Depression in HIV Care Settings
Status: Archived
Massachusetts General Hospital
mi
from
Boston, MA
Therapy Targeting Depression and HIV Treatment Adherence (The TRIAD Study)
Efficacy of CBT for Adherence and Depression in HIV Care Settings
Status: Archived
Updated: 1/1/1970
Massachusetts General Hospital
mi
from
Boston, MA
Therapy Targeting Depression and HIV Treatment Adherence (The TRIAD Study)
Efficacy of CBT for Adherence and Depression in HIV Care Settings
Status: Archived
Fenway Community Health Center
mi
from
Boston, MA
Therapy Targeting Depression and HIV Treatment Adherence (The TRIAD Study)
Efficacy of CBT for Adherence and Depression in HIV Care Settings
Status: Archived
Updated: 1/1/1970
Fenway Community Health Center
mi
from
Boston, MA
Therapy Targeting Depression and HIV Treatment Adherence (The TRIAD Study)
Efficacy of CBT for Adherence and Depression in HIV Care Settings
Status: Archived
The Miriam Hospital Weight Control and Diabetes Research Center
mi
from
Providence, RI
Therapy Targeting Depression and HIV Treatment Adherence (The TRIAD Study)
Efficacy of CBT for Adherence and Depression in HIV Care Settings
Status: Archived
Updated: 1/1/1970
The Miriam Hospital Weight Control and Diabetes Research Center
mi
from
Providence, RI
Therapy Targeting Depression and HIV Treatment Adherence (The TRIAD Study)
Efficacy of CBT for Adherence and Depression in HIV Care Settings
Status: Archived
Butler Hospital Memory & Aging Program
mi
from
Providence, RI
Therapy Targeting Depression and HIV Treatment Adherence (The TRIAD Study)
Efficacy of CBT for Adherence and Depression in HIV Care Settings
Status: Archived
Updated: 1/1/1970
Butler Hospital Memory & Aging Program
mi
from
Providence, RI
A Study in Relapse Prevention of Treatment-resistant Depression
A Study to Assess the Long-Term Efficacy and Safety of Olanzapine and Fluoxetine Combination Versus Fluoxetine Only in the Relapse Prevention of Stabilized Patients With Treatment-Resistant Depression
Status: Archived
Dana-Farber / Harvard Cancer Center
mi
from
Boston, MA
A Study in Relapse Prevention of Treatment-resistant Depression
A Study to Assess the Long-Term Efficacy and Safety of Olanzapine and Fluoxetine Combination Versus Fluoxetine Only in the Relapse Prevention of Stabilized Patients With Treatment-Resistant Depression
Status: Archived
Updated: 1/1/1970
Dana-Farber / Harvard Cancer Center
mi
from
Boston, MA
A Study in Relapse Prevention of Treatment-resistant Depression
A Study to Assess the Long-Term Efficacy and Safety of Olanzapine and Fluoxetine Combination Versus Fluoxetine Only in the Relapse Prevention of Stabilized Patients With Treatment-Resistant Depression
Status: Archived
Clinical Research Facility
mi
from
Hartford, CT
A Study in Relapse Prevention of Treatment-resistant Depression
A Study to Assess the Long-Term Efficacy and Safety of Olanzapine and Fluoxetine Combination Versus Fluoxetine Only in the Relapse Prevention of Stabilized Patients With Treatment-Resistant Depression
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Hartford, CT
A Study in Relapse Prevention of Treatment-resistant Depression
A Study to Assess the Long-Term Efficacy and Safety of Olanzapine and Fluoxetine Combination Versus Fluoxetine Only in the Relapse Prevention of Stabilized Patients With Treatment-Resistant Depression
Status: Archived
Clinical Research Facility
mi
from
Washington,
A Study in Relapse Prevention of Treatment-resistant Depression
A Study to Assess the Long-Term Efficacy and Safety of Olanzapine and Fluoxetine Combination Versus Fluoxetine Only in the Relapse Prevention of Stabilized Patients With Treatment-Resistant Depression
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Washington,
A Study in Relapse Prevention of Treatment-resistant Depression
A Study to Assess the Long-Term Efficacy and Safety of Olanzapine and Fluoxetine Combination Versus Fluoxetine Only in the Relapse Prevention of Stabilized Patients With Treatment-Resistant Depression
Status: Archived
Aurora Memorial Hospital of Burlington
mi
from
Burlington, WI
A Study in Relapse Prevention of Treatment-resistant Depression
A Study to Assess the Long-Term Efficacy and Safety of Olanzapine and Fluoxetine Combination Versus Fluoxetine Only in the Relapse Prevention of Stabilized Patients With Treatment-Resistant Depression
Status: Archived
Updated: 1/1/1970
Aurora Memorial Hospital of Burlington
mi
from
Burlington, WI
A Study in Relapse Prevention of Treatment-resistant Depression
A Study to Assess the Long-Term Efficacy and Safety of Olanzapine and Fluoxetine Combination Versus Fluoxetine Only in the Relapse Prevention of Stabilized Patients With Treatment-Resistant Depression
Status: Archived
Maine Center for Cancer Medicine and Blood Disorders - Scarborough
mi
from
Scarborough, ME
A Study in Relapse Prevention of Treatment-resistant Depression
A Study to Assess the Long-Term Efficacy and Safety of Olanzapine and Fluoxetine Combination Versus Fluoxetine Only in the Relapse Prevention of Stabilized Patients With Treatment-Resistant Depression
Status: Archived
Updated: 1/1/1970
Maine Center for Cancer Medicine and Blood Disorders - Scarborough
mi
from
Scarborough, ME
A Study in Relapse Prevention of Treatment-resistant Depression
A Study to Assess the Long-Term Efficacy and Safety of Olanzapine and Fluoxetine Combination Versus Fluoxetine Only in the Relapse Prevention of Stabilized Patients With Treatment-Resistant Depression
Status: Archived
University of Vermont College of Medicine
mi
from
Burlington, VT
A Study in Relapse Prevention of Treatment-resistant Depression
A Study to Assess the Long-Term Efficacy and Safety of Olanzapine and Fluoxetine Combination Versus Fluoxetine Only in the Relapse Prevention of Stabilized Patients With Treatment-Resistant Depression
Status: Archived
Updated: 1/1/1970
University of Vermont College of Medicine
mi
from
Burlington, VT
A Study in Relapse Prevention of Treatment-resistant Depression
A Study to Assess the Long-Term Efficacy and Safety of Olanzapine and Fluoxetine Combination Versus Fluoxetine Only in the Relapse Prevention of Stabilized Patients With Treatment-Resistant Depression
Status: Archived
Clinical Research Facility
mi
from
Hazard, KY
A Study in Relapse Prevention of Treatment-resistant Depression
A Study to Assess the Long-Term Efficacy and Safety of Olanzapine and Fluoxetine Combination Versus Fluoxetine Only in the Relapse Prevention of Stabilized Patients With Treatment-Resistant Depression
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Hazard, KY
A Study in Relapse Prevention of Treatment-resistant Depression
A Study to Assess the Long-Term Efficacy and Safety of Olanzapine and Fluoxetine Combination Versus Fluoxetine Only in the Relapse Prevention of Stabilized Patients With Treatment-Resistant Depression
Status: Archived
Clinical Research Facility
mi
from
Bethesda, MD
A Study in Relapse Prevention of Treatment-resistant Depression
A Study to Assess the Long-Term Efficacy and Safety of Olanzapine and Fluoxetine Combination Versus Fluoxetine Only in the Relapse Prevention of Stabilized Patients With Treatment-Resistant Depression
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Bethesda, MD
A Study in Relapse Prevention of Treatment-resistant Depression
A Study to Assess the Long-Term Efficacy and Safety of Olanzapine and Fluoxetine Combination Versus Fluoxetine Only in the Relapse Prevention of Stabilized Patients With Treatment-Resistant Depression
Status: Archived
Clinical Research Facility
mi
from
Boston, MA
A Study in Relapse Prevention of Treatment-resistant Depression
A Study to Assess the Long-Term Efficacy and Safety of Olanzapine and Fluoxetine Combination Versus Fluoxetine Only in the Relapse Prevention of Stabilized Patients With Treatment-Resistant Depression
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Boston, MA
A Study in Relapse Prevention of Treatment-resistant Depression
A Study to Assess the Long-Term Efficacy and Safety of Olanzapine and Fluoxetine Combination Versus Fluoxetine Only in the Relapse Prevention of Stabilized Patients With Treatment-Resistant Depression
Status: Archived
Hartford Hospital- The Institute of Living
mi
from
Hartford, CT
A Study in Relapse Prevention of Treatment-resistant Depression
A Study to Assess the Long-Term Efficacy and Safety of Olanzapine and Fluoxetine Combination Versus Fluoxetine Only in the Relapse Prevention of Stabilized Patients With Treatment-Resistant Depression
Status: Archived
Updated: 1/1/1970
Hartford Hospital- The Institute of Living
mi
from
Hartford, CT
A Study in Relapse Prevention of Treatment-resistant Depression
A Study to Assess the Long-Term Efficacy and Safety of Olanzapine and Fluoxetine Combination Versus Fluoxetine Only in the Relapse Prevention of Stabilized Patients With Treatment-Resistant Depression
Status: Archived
Clinical Research Facility
mi
from
Nashua, NH
A Study in Relapse Prevention of Treatment-resistant Depression
A Study to Assess the Long-Term Efficacy and Safety of Olanzapine and Fluoxetine Combination Versus Fluoxetine Only in the Relapse Prevention of Stabilized Patients With Treatment-Resistant Depression
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Nashua, NH